324 related articles for article (PubMed ID: 38672649)
21. Thrombin is a potent inducer of connective tissue growth factor production via proteolytic activation of protease-activated receptor-1.
Chambers RC; Leoni P; Blanc-Brude OP; Wembridge DE; Laurent GJ
J Biol Chem; 2000 Nov; 275(45):35584-91. PubMed ID: 10952976
[TBL] [Abstract][Full Text] [Related]
22. Tissue Factor, Thrombosis, and Chronic Kidney Disease.
Oe Y; Takahashi N
Biomedicines; 2022 Oct; 10(11):. PubMed ID: 36359257
[TBL] [Abstract][Full Text] [Related]
23. Protease signaling in tumor progression.
Camerer E
Thromb Res; 2007; 120 Suppl 2():S75-81. PubMed ID: 18023718
[TBL] [Abstract][Full Text] [Related]
24. Tissue factor, coagulation proteases, and protease-activated receptors in endotoxemia and sepsis.
Pawlinski R; Mackman N
Crit Care Med; 2004 May; 32(5 Suppl):S293-7. PubMed ID: 15118533
[TBL] [Abstract][Full Text] [Related]
25. Thrombin Signaling Promotes Pancreatic Adenocarcinoma through PAR-1-Dependent Immune Evasion.
Yang Y; Stang A; Schweickert PG; Lanman NA; Paul EN; Monia BP; Revenko AS; Palumbo JS; Mullins ES; Elzey BD; Janssen EM; Konieczny SF; Flick MJ
Cancer Res; 2019 Jul; 79(13):3417-3430. PubMed ID: 31048498
[TBL] [Abstract][Full Text] [Related]
26. Protease-activated receptors in cancer: A systematic review.
Han N; Jin K; He K; Cao J; Teng L
Oncol Lett; 2011 Jul; 2(4):599-608. PubMed ID: 22848234
[TBL] [Abstract][Full Text] [Related]
27. Protease-activated receptor 2 blocking peptide counteracts endotoxin-induced inflammation and coagulation and ameliorates renal fibrin deposition in a rat model of acute renal failure.
Jesmin S; Gando S; Zaedi S; Prodhan SH; Sawamura A; Miyauchi T; Hiroe M; Yamaguchi N
Shock; 2009 Dec; 32(6):626-32. PubMed ID: 19333145
[TBL] [Abstract][Full Text] [Related]
28. Exclusion of known protease-activated receptors in factor VIIa-induced signal transduction.
Petersen LC; Thastrup O; Hagel G; Sørensen BB; Freskgård PO; Rao LV; Ezban M
Thromb Haemost; 2000 Apr; 83(4):571-6. PubMed ID: 10780319
[TBL] [Abstract][Full Text] [Related]
29. Protease-activated receptors - biology and role in cancer.
Hempel D; Sierko E; Wojtukiewicz MZ
Postepy Hig Med Dosw (Online); 2016 Jul; 70(0):775-86. PubMed ID: 27383574
[TBL] [Abstract][Full Text] [Related]
30. Pleiotropic effects of factor Xa and thrombin: what to expect from novel anticoagulants.
Spronk HM; de Jong AM; Crijns HJ; Schotten U; Van Gelder IC; Ten Cate H
Cardiovasc Res; 2014 Mar; 101(3):344-51. PubMed ID: 24385341
[TBL] [Abstract][Full Text] [Related]
31. Protease-activated receptors: contribution to physiology and disease.
Ossovskaya VS; Bunnett NW
Physiol Rev; 2004 Apr; 84(2):579-621. PubMed ID: 15044683
[TBL] [Abstract][Full Text] [Related]
32. Role of current and emerging antithrombotics in thrombosis and cancer.
Mousa SA
Drugs Today (Barc); 2006 May; 42(5):331-50. PubMed ID: 16801996
[TBL] [Abstract][Full Text] [Related]
33. Biased signaling of protease-activated receptors.
Zhao P; Metcalf M; Bunnett NW
Front Endocrinol (Lausanne); 2014; 5():67. PubMed ID: 24860547
[TBL] [Abstract][Full Text] [Related]
34. Protease-activated receptors (PARs)--biology and role in cancer invasion and metastasis.
Wojtukiewicz MZ; Hempel D; Sierko E; Tucker SC; Honn KV
Cancer Metastasis Rev; 2015 Dec; 34(4):775-96. PubMed ID: 26573921
[TBL] [Abstract][Full Text] [Related]
35. Factor Xa and thrombin evoke additive calcium and proinflammatory responses in endothelial cells subjected to coagulation.
Daubie V; Cauwenberghs S; Senden NH; Pochet R; Lindhout T; Buurman WA; Heemskerk JW
Biochim Biophys Acta; 2006 Aug; 1763(8):860-9. PubMed ID: 16765466
[TBL] [Abstract][Full Text] [Related]
36. Stimulation of naïve monocytes and PBMCs with coagulation proteases results in thrombin-mediated and PAR-1-dependent cytokine release and cell proliferation in PBMCs only.
Nieuwenhuizen L; Falkenburg WJ; Schutgens RE; Roosendaal G; van Veghel K; Biesma DH; Lafeber FP
Scand J Immunol; 2013 May; 77(5):339-49. PubMed ID: 23421536
[TBL] [Abstract][Full Text] [Related]
37. Protease-activated receptor 2 promotes actomyosin dependent transforming microvesicles generation from human breast cancer.
Das K; Prasad R; Singh A; Bhattacharya A; Roy A; Mallik S; Mukherjee A; Sen P
Mol Carcinog; 2018 Dec; 57(12):1707-1722. PubMed ID: 30129687
[TBL] [Abstract][Full Text] [Related]
38. Blood coagulation-dependent inflammation. Coagulation-dependent inflammation and inflammation-dependent thrombosis.
Strukova S
Front Biosci; 2006 Jan; 11():59-80. PubMed ID: 16146714
[TBL] [Abstract][Full Text] [Related]
39. Coagulation factor VIIa-mediated protease-activated receptor 2 activation leads to β-catenin accumulation via the AKT/GSK3β pathway and contributes to breast cancer progression.
Roy A; Ansari SA; Das K; Prasad R; Bhattacharya A; Mallik S; Mukherjee A; Sen P
J Biol Chem; 2017 Aug; 292(33):13688-13701. PubMed ID: 28522609
[TBL] [Abstract][Full Text] [Related]
40. Thrombin and activated coagulation factor X stimulate the release of cytokines and fibronectin from nasal polyp fibroblasts
Shimizu S; Tojima I; Takezawa K; Matsumoto K; Kouzaki H; Shimizu T
Am J Rhinol Allergy; 2017 Jan; 31(1):13-18. PubMed ID: 28234145
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
